Canadian medical reactor gets nod to restart

Jul 07, 2010

Canada's nuclear safety commission authorized Wednesday the restarting of a reactor that produced one-third of the world's supply of medical isotopes before it closed for repairs last year.

The half-century old National Research Universal reactor in Chalk River, Ontario, 185 kilometers (115 miles) northwest of Ottawa, could be restarted at the end of the month.

It was shut down in May 2009 after a leak of inside the reactor.

Atomic Energy of Canada Limited (AECL) had initially estimated the stoppage would last only a few months.

produced by the are used to diagnose cancer and heart disease in patients around the world. The shutdown led to a global shortage of the precious radioactive material.

Explore further: Errata frequently seen in medical literature

add to favorites email to friend print save as pdf

Related Stories

Rebooting of Canadian medical isotope reactor delayed

Aug 13, 2009

A Canadian reactor that produced one-third of the world's supply of medical isotopes before it closed in May for repairs will remain offline at least until early 2010, nuclear authorities said Thursday.

A top supplier of medical isotopes closed through 2009

Jul 08, 2009

An aging Canadian nuclear reactor responsible for production of one-third of the isotopes used in medical radiation treatment around the world will be out of service through at least the end of 2009, authorities said Wednesday.

Officials seek cause of reactor shutdown

Nov 03, 2006

Authorities are investigating the cause of the nuclear reactor shutdown at Three Mile Island near Harrisburg, Pa., although no radiation leaked in the incident.

Recommended for you

Errata frequently seen in medical literature

21 hours ago

(HealthDay)—Errata, including those that may materially change the interpretation of data, are frequent in medical publications, according to a study published in the August issue of The American Journal of ...

Seven US-based researchers share $1.3M eyesight prize

Sep 10, 2014

Seven U.S.-based researchers are sharing a €1 million ($1.3 million) prize from a Portuguese foundation for their work developing treatment for angiogenic diseases of the retina, the leading cause of blindness in the developed ...

User comments : 0